IL4 and Darier disease: Dupilumab, a monoclonal antibody targeting IL-4 and IL-13, has shown excellent efficacy in alleviating pruritus in other dermatologic conditions [59] and may also help manage itch in patients with Darier disease, as evidenced by a recent case report [60].